Close

Registration is free and only takes a moment. If you have already registered, please log in now.

Create Account
Forgot your password?
Log In
  • Links
  • PMC Free PDF
  • PMC Free Full Text
  • Publisher Full Text
  • Authors
  • Smith GC
  • MESH
  • Clinical Trials as Topic
  • Female
  • Humans
  • Mass Screening
  • Placenta
  • Poverty
  • Pre-Eclampsia
  • Pregnancy
  • Pregnancy Outcome

Unbound MEDLINE

Researching new methods of screening for adverse pregnancy outcome: lessons from pre-eclampsia.

Links

  • PMC Free PDF
  • PMC Free Full Text
  • Publisher Full Text
  • Authors

    Smith GC

    Institution

    Department of Obstetrics and Gynaecology, Cambridge University, Cambridge, United Kingdom. gcss2@cam.ac.uk

    Source

    PLoS medicine 9:7 2012 pg e1001274

    MeSH

    Clinical Trials as Topic
    Female
    Humans
    Mass Screening
    Placenta
    Poverty
    Pre-Eclampsia
    Pregnancy
    Pregnancy Outcome

    Pub Type(s)

    Journal Article
    Research Support, Non-U.S. Gov't
    Review

    Language

    eng

    PubMed ID

    22859910

    Related Citations

    • Comparison between three-dimensional placental volume at 12 weeks and uterine artery impedance/notching at 22 weeks in screening for pregnancy-induced hypertension, pre-eclampsia and fetal growth restriction in a low-risk population.
    • Mid-trimester uterine artery Doppler screening as a predictor of adverse pregnancy outcome in high-risk women.
    • Screening for pre-eclampsia--lessons from aneuploidy screening.
    • Economic assessment of screening for pre-eclampsia.
    • [Pre-eclampsia screening in first and second trimester].
    • Doppler investigation of uteroplacental blood flow resistance in the second trimester: a screening study for pre-eclampsia and intrauterine growth retardation.
    • Serum screening with Down's syndrome markers to predict pre-eclampsia and small for gestational age: systematic review and meta-analysis.
    • Uterine artery Doppler screening for adverse pregnancy outcome.
    More
    unbound logo
    • Home »
    • Contact Us »
    • Help »
    • Privacy / Disclaimer »
    • Terms of Service »
    • Log In »
    • twitter
    • facebook
    © 2000–2013 Unbound Medicine, Inc. All rights reserved